Jocelyn H. Leu

Three Multicenter, Randomized, Double‐Blind, Placebo‐Controlled Studies Evaluating the Efficacy and Safety of Ustekinumab in Axial Spondyloarthritis

Atul Deodhar, Lianne S. Gensler, Joachim Sieper et al. · Arthritis & Rheumatology · 2018 · 311 citations · Full text

Golimumab and Beta-Cell Function in Youth with New-Onset Type 1 Diabetes

Teresa Quattrin, Michael J. Haller, Andrea K. Steck et al. · New England Journal of Medicine · 2020 · 239 citations

Clinical efficacy, radiographic and safety findings through 5 years of subcutaneous golimumab treatment in patients with active psoriatic arthritis: results from a long-term extension of a randomised, placebo-controlled trial (the GO-REVEAL study)

Arthur Kavanaugh, Iain B. McInnes, Philip J. Mease et al. · Annals of the Rheumatic Diseases · 2014 · 125 citations · Full text

Subcutaneous golimumab for children with active polyarticular-course juvenile idiopathic arthritis: results of a multicentre, double-blind, randomised-withdrawal trial

Hermine I. Brunner, Nicolino Ruperto, Nikolay Tzaribachev et al. · Annals of the Rheumatic Diseases · 2017 · 120 citations · Full text

Adalimumab for moderate to severe chronic plaque psoriasis: efficacy and safety of retreatment and disease recurrence following withdrawal from therapy

Kim Papp, Jeffrey Crowley, J.‐P. Ortonne et al. · British Journal of Dermatology · 2010 · 114 citations